Humacyte (HUMA) Retained Earnings (2020 - 2026)
Humacyte (HUMA) reported Retained Earnings of -$744.5 million for Q1 2026, down 15.09% year-over-year from -$876.8 million in Q1 2025, and down 2.44% quarter-over-quarter from -$726.8 million in Q4 2025.
Humacyte (HUMA) Retained Earnings (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Retained Earnings data on file, last reported at -$744.5 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$744.5 million, down 15.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$744.5 million (down 15.09% YoY), and the FY2025 annual result was -$726.8 million, down 5.95% from the prior year.
- Retained Earnings fell to -$744.5 million in Q1 2026 per HUMA's latest filing, from -$726.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$397.5 million in Q2 2022 and troughed at -$744.5 million in Q1 2026.
- A 5-year average of -$572.4 million and a median of -$569.2 million in 2024 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 7.52% in 2022 and fell as far as 5319.24% in 2022.
- A 5-year view of Retained Earnings shows it stood at -$426.5 million in 2022, then dropped by 25.97% to -$537.3 million in 2023, then declined by 27.67% to -$686.0 million in 2024, then retreated by 5.95% to -$726.8 million in 2025, then slipped by 2.44% to -$744.5 million in 2026.
- Business Quant data shows HUMA's Retained Earnings at -$744.5 million in Q1 2026, -$726.8 million in Q4 2025, and -$702.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -744.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -744.50 Mn |
| Dec 31, 2025 | -726.80 Mn |
| Sep 30, 2025 | -702.04 Mn |
| Jun 30, 2025 | -684.53 Mn |
| Mar 31, 2025 | -646.90 Mn |
| Dec 31, 2024 | -686.02 Mn |
| Sep 30, 2024 | -665.10 Mn |
| Jun 30, 2024 | -625.90 Mn |
| Mar 31, 2024 | -569.21 Mn |
| Dec 31, 2023 | -537.31 Mn |
| Sep 30, 2023 | -512.20 Mn |
| Jun 30, 2023 | -486.20 Mn |
| Mar 31, 2023 | -463.51 Mn |
| Dec 31, 2022 | -426.54 Mn |
| Sep 30, 2022 | -422.80 Mn |
| Jun 30, 2022 | -397.50 Mn |
| Mar 31, 2022 | -434.40 Mn |
| Dec 31, 2021 | -414.57 Mn |
| Sep 30, 2021 | -457.20 Mn |
| Jun 30, 2021 | -7.73 Mn |